Free Trial

GSK (GSK) Insider Trading & Ownership

GSK logo
$33.35 -0.64 (-1.88%)
(As of 11/15/2024 ET)

GSK (NYSE:GSK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$22.34 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get GSK Insider Trade Alerts

Want to know when executives and insiders are buying or selling GSK stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GSK Insider Buying and Selling by Quarter

GSK Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2024Plc GskMajor ShareholderBuy2,791,930$8.00$22,335,440.00  
(Data available from 1/1/2013 forward)

GSK Insider Trading Activity - Frequently Asked Questions

The list of insiders at GSK includes Plc Gsk. Learn more on insiders at GSK.

10.00% of GSK stock is owned by insiders. Learn more on GSK's insider holdings.

The following insider purchased GSK shares in the last 24 months: Plc Gsk ($22,335,440.00).

Insiders have purchased a total of 2,791,930 GSK shares in the last 24 months for a total of $22,335,440.00 bought.

GSK Key Executives

  • Ms. Emma Natasha Walmsley (Age 55)
    CEO & Director
    Compensation: $6.85M
  • Ms. Julie Belita Brown (Age 62)
    CFO & Executive Director
    Compensation: $6.54M
  • Ms. Shobie Ramakrishnan (Age 53)
    Chief Digital & Technology Officer
  • Mr. Tony Wood
    Chief Scientific Officer and Head of R&D
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Senior VP & Group General Counsel of Legal & Compliance
  • Ms. Sally JacksonMs. Sally Jackson
    Senior Vice President of Global Communications & CEO Office
  • Mr. David Simon Redfern BSc (Hons) (Age 58)
    CA, President of Corporate Development
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. Philip C. Thomson
    President of Global Affairs


This page (NYSE:GSK) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners